bioMerieux S.A. Stock
Your prediction
bioMerieux S.A. Stock
With only a change of €0.10 (0.090%) the bioMerieux S.A. price is nearly unchanged from yesterday.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for bioMerieux S.A. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of bioMerieux S.A. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
S********** s********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of bioMerieux S.A. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| bioMerieux S.A. | 0.090% | 2.385% | -1.197% | 4.990% | 4.276% | 8.296% | -10.583% |
| EssilorLuxottica SA | -0.350% | -4.831% | -12.194% | 23.187% | 21.084% | 55.282% | 120.692% |
| Sartorius Stedim Biotech S.A. | -0.580% | -2.720% | 6.087% | 6.632% | 12.871% | -35.208% | -30.121% |
| Dexcom Inc. | -2.250% | 1.386% | 10.930% | -24.350% | -24.450% | -48.557% | -20.474% |
Comments
bioMérieux S.A. (OTCMKTS: BMXMF) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Show more
Ratings data for BMXMF provided by MarketBeat
